Clinical Trial: A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678970) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors' on June 25.

Brief Summary: This study is an open-label, multicenter, non-randomized Phase I clinical study with dose-escalation and expansion cohorts, designed to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advanced or metastatic gastrointestinal tumors and other solid tumors.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Gastrointestinal Tumor Solid Tumor

Intervention: DRUG: SI-B0...